Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Sernovas Cell Pouch technology works well.

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Jun 28, 2021 10:02am

189 Views

Post# 33459216

RE:RE:Sernovas Cell Pouch technology works well.

Sertoli, Age-X, Conformal Coating. 3 strikes and you're out?

Sernova should really just sell it's pouch (patents) to Vertex at 500 million. However, that ship has probably already sailed.

MustangSalley wrote:

Stockwonder wrote: This is huge. The patient is very happy with this. a billion dollar market now opens to Sernova.

Yes the first patient is insulin independent .... but from the portal vein top up or from the pouch itself? The other patients are not insulin independent so far . Immunosuppresion needs to be solved for a cure for TD1 . Sva apparently has a solution , but for some reason nothing has been done with immune coating. Let's hope it does not go the way of Serotoli cells.